For Great Britain healthcare professionals only
Hosting partners
Click here for Great Britain Prescribing Information for Kerendia▼ (finerenone). Adverse Event Reporting details can be found at the bottom of the page
Click here for Great Britain Prescribing Information for Kerendia▼ (finerenone). Adverse Event Reporting details can be found at the bottom of the page
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Click here for Great Britain Prescribing Information for Kerendia▼ (finerenone). Adverse Event Reporting details can be found at the bottom of the page
Professor Philip Kalra and Dr Arif Khwaja discuss models of care for people with T2D and CKD, including NHS prevention strategies such as CVDPREVENT, and the implications of the Renal Services Transformation Programme for this population. Practical case studies will be introduced during the video to illustrate treatment and referral decisions for these patients.
Professor Philip Kalra and Professor Smeeta Sinha discuss the potential role of Kerendia▼ (finerenone) in optimising the diabetic kidney disease (DKD) patient pathway, from early patient identification and initiation of treatment, to knowing how to manage hyperkalaemia and when to refer to a nephrologist.
Professor Philip Kalra and Dr Kieran McCafferty examine the burden of chronic kidney disease (CKD) in adults with type 2 diabetes (T2D), assess the clinical trial data for Kerendia▼ (finerenone) and its impact on the progression of CKD associated with T2D, and outline prescribing considerations for Kerendia in people with CKD associated with T2D.
Alternatively, open your phone camera application, hold it over the QR code and tap the link that appears.
PP-KER-GB-0531 | October 2023
The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions. Copyright 2023 Oxbridge Solutions Ltd®. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions Ltd® receives funding from advertising but maintains editorial independence. GPnotebook stores small data files on your computer called cookies so that we can recognise you and provide you with the best service. If you do not want to receive cookies please do not use GPnotebook.
Are you a Great Britain healthcare professional?
The information is intended for Great Britain healthcare professionals only.
Please confirm below.
You are leaving GP Notebook
GP Notebook is not responsible for content hosted on third party websites.
